Benzydamine Hydrochloride + Cetylpyridinium Chloride
This medicine should always be used exactly as described in this patient information leaflet or as directed by a doctor or pharmacist.
Septolete Ultra Eucalyptus Flavor lozenges are an anti-inflammatory, analgesic, and antiseptic medicine for local use in the mouth. The lozenges disinfect the mouth and throat, reducing the symptoms of throat inflammation, such as pain, redness, and swelling. Septolete Ultra Eucalyptus Flavor lozenges are used as an anti-inflammatory, analgesic, and antiseptic in the treatment of:
If after 3 days there is no improvement or the patient feels worse, they should consult a doctor.
Before starting to use Septolete Ultra Eucalyptus Flavor, the patient should discuss it with their doctor or pharmacist.
Septolete Ultra Eucalyptus Flavor should not be used for more than 7 days. If symptoms worsen or do not improve after 3 days, or if other symptoms such as fever occur, the patient should contact a doctor.
The use of local medicines, especially for a longer period, may lead to irritation; in such a case, treatment should be discontinued.
Septolete Ultra Eucalyptus Flavor should not be used in combination with anionic compounds, such as those found in toothpastes; therefore, it is not recommended to use the medicine directly before or after brushing teeth.
Septolete Ultra Eucalyptus Flavor should not be used in children under 6 years of age, as the lozenges are not indicated for this age group.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Septolete Ultra Eucalyptus Flavor should not be used at the same time as other antiseptic medicines.
The patient should not take Septolete Ultra Eucalyptus Flavor lozenges at the same time as milk, as milk reduces their effectiveness.
The patient should not use Septolete Ultra Eucalyptus Flavor before or during meals. The patient should not drink or eat for at least 1 hour after using Septolete Ultra Eucalyptus Flavor.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
It is not recommended to use Septolete Ultra Eucalyptus Flavor during pregnancy.
Before using Septolete Ultra Eucalyptus Flavor while breastfeeding, the patient should discuss it with their doctor. The doctor will advise whether to stop breastfeeding or stop the treatment.
Septolete Ultra Eucalyptus Flavor has no influence or negligible influence on the ability to drive and use machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be used exactly as described in this patient information leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
Adults
The recommended dosage is 3 to 4 hard lozenges per day. A lozenge should be slowly sucked in the mouth every 3 to 6 hours.
Adolescents over 12 years of age
The recommended dosage is 3 to 4 hard lozenges per day. A lozenge should be slowly sucked in the mouth every 3 to 6 hours.
Children from 6 to 12 years of age
The recommended dosage is 3 hard lozenges per day. A lozenge should be slowly sucked in the mouth every 3 to 6 hours.
Children under 6 years of age
Septolete Ultra Eucalyptus Flavor is contraindicated in children under 6 years of age.
The patient should not use Septolete Ultra Eucalyptus Flavor before or during meals.
The patient should not drink or eat for at least 1 hour after using the medicine.
For optimal effect, it is not recommended to use the medicine directly before or after brushing teeth.
The medicine should not be used for more than 7 days. If symptoms worsen or do not improve after 3 days, or if other symptoms such as fever occur, the patient should consult a doctor.
In case of accidental overdose, the patient should immediately inform their doctor or go to the nearest hospital.
The patient should not take a double dose to make up for a missed dose.
In case of any further doubts about using this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rare (may affect up to 1 in 1000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
These symptoms are usually temporary. However, if they occur, it is recommended to consult a doctor or pharmacist.
By following the instructions in the patient information leaflet, the risk of side effects can be reduced.
If the patient experiences any side effects, including those not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Medicinal Product Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after EXP. The expiry date refers to the last day of the month.
Store in the original package to protect from light.
There are no special storage temperature requirements.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Round, blue-white to blue lozenges with beveled edges. Small scratches may be present.
Diameter of the lozenge: 18.0 mm - 19.0 mm, thickness: 7.0 mm - 8.0 mm.
Blisters of PVC/PE/PVDC/Aluminum, in a cardboard box.
Pack sizes: 16 or 24 hard lozenges.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
TAD Pharma GmbH
Heinz-Lohmann-Straße 5
27472 Cuxhaven
Germany
KRKA-POLSKA Sp. z o.o.
Równoległa 5
02-235 Warsaw
Date of last revision of the leaflet:30.11.2023
Bulgaria | Септолете тотал евкалипт |
Croatia | Septolete duo eukaliptus |
Czech Republic | Septabene eukalyptus |
Estonia | Septolete omni eucalyptus |
Finland | Septabene eukalyptus |
Lithuania | Septabene eukaliptų skonio 3 mg/1 mg kietosios pastilės |
Latvia | Septabene ar eikaliptu 3 mg/1 mg sūkājamās tabletes |
Malta | SEPTOLETE TOTAL Eucalyptus 3 mg/1 mg lozenge |
Poland | Septolete ultra o smaku eukaliptusowym |
Portugal | Septolete Duo eucalipto |
Romania | Septolete omni eucalipt |
Slovakia | Septolete extra eukalyptus 3 mg/1 mg tvrdé pastilky |
Slovenia | Septabene z okusom evkalipta 3 mg/1 mg pastile |
Hungary | Septolete extra eukaliptusz ízű 3 mg/1 mg szopogató tabletta |
Italy | Septolete |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.